Decitabine/Cedazuridine as Maintenance Therapy

A Phase Ib Study of Oral Decitabine/Cedazuridine as Maintenance Therapy Following Allogeneic Hematopoietic Cell Transplantation for Patients With Myeloid Neoplasms

Arms / Cohorts

Experimental:Dose Escalation: Inqovi

Accepting patients

Experimental:Recommended Phase 2 Dose Expansion: Inqovi

Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print this trial to share with your doctor.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.